Macrophages in immunoregulation and therapeutics
S Chen, AFUH Saeed, Q Liu, Q Jiang, H Xu… - … and Targeted Therapy, 2023 - nature.com
Macrophages exist in various tissues, several body cavities, and around mucosal surfaces
and are a vital part of the innate immune system for host defense against many pathogens …
and are a vital part of the innate immune system for host defense against many pathogens …
[HTML][HTML] The macrophage polarization in inflammatory dermatosis and its potential drug candidates
Q Sun, S Hu, Z Lou, J Gao - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Inflammatory dermatosis is characterized by persistent inflammatory infiltration and hard
repair of diseased skin. As a member of the human innate immune cells, macrophages …
repair of diseased skin. As a member of the human innate immune cells, macrophages …
Back to the future: targeting the extracellular matrix to treat systemic sclerosis
A Leask, A Naik, RJ Stratton - Nature Reviews Rheumatology, 2023 - nature.com
Fibrosis is the excessive deposition of a stable extracellular matrix (ECM); fibrotic tissue is
composed principally of highly crosslinked type I collagen and highly contractile …
composed principally of highly crosslinked type I collagen and highly contractile …
Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis
Immune cells are fundamental regulators of extracellular matrix (ECM) production by
fibroblasts and have important roles in determining extent of fibrosis in response to …
fibroblasts and have important roles in determining extent of fibrosis in response to …
[HTML][HTML] Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis
G Villanueva-Martin, M Acosta-Herrera… - Journal of …, 2023 - Elsevier
Systemic sclerosis (SSc) is a complex disease that affects the connective tissue, causing
fibrosis. SSc patients show altered immune cell composition and activation in the peripheral …
fibrosis. SSc patients show altered immune cell composition and activation in the peripheral …
Macrophage: key player in the pathogenesis of autoimmune diseases
S Yang, M Zhao, S Jia - Frontiers in Immunology, 2023 - frontiersin.org
The macrophage is an essential part of the innate immune system and also serves as the
bridge between innate immunity and adaptive immune response. As the initiator and …
bridge between innate immunity and adaptive immune response. As the initiator and …
Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis
K Zhao, C Kong, N Shi, J Jiang, P Li - Frontiers in Immunology, 2023 - frontiersin.org
Systemic sclerosis (SSc) is an intricate systemic autoimmune disease with pathological
features such as vascular injury, immune dysregulation, and extensive fibrosis of the skin …
features such as vascular injury, immune dysregulation, and extensive fibrosis of the skin …
Role of cellular senescence in the pathogenesis of systemic sclerosis
There is increasing evidence implicating cellular senescence in SSc. The mechanisms
underlying premature cellular senescence in SSc, and its potential role in pathogenesis …
underlying premature cellular senescence in SSc, and its potential role in pathogenesis …
Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis
D Abraham, A Lescoat, R Stratton - Molecular Aspects of Medicine, 2024 - Elsevier
Systemic sclerosis (also called scleroderma, SSc) is a chronic autoimmune disorder
characterized by excessive collagen deposition leading to skin fibrosis and various internal …
characterized by excessive collagen deposition leading to skin fibrosis and various internal …
PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry
M Fernández‐Cortés, D Delgado‐Bellido… - The Journal of …, 2023 - Wiley Online Library
Vasculogenic mimicry (VM) describes the ability of highly aggressive tumor cells to develop
pseudovascular structures without the participation of endothelial cells. PARP1 is implicated …
pseudovascular structures without the participation of endothelial cells. PARP1 is implicated …